| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |